Pop Mart Shares Surge in Hong Kong After First Buyback in Nearly Two Years 
Renault Group Global Sales Rise 3.2% in 2025 on Strong International and EV Demand 
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure 
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production 
U.S. Transportation Board Sends Union Pacific–Norfolk Southern Merger Back for Revision 
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling 
California Attorney General Orders xAI to Halt Illegal Grok Deepfake Imagery 
TSMC Shares Hit Record High as AI Chip Demand Fuels Strong Q4 Earnings 
BYD Shares Rise in Hong Kong on Reports of Battery Supply Talks With Ford 
Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition 
White House Pressures PJM to Act as Data Center Energy Demand Threatens Grid Reliability 
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation 
Lululemon Founder Chip Wilson Escalates Proxy Fight to Remove Advent From Board 
BHP Posts Record Iron Ore Output as China Pricing Pressures Loom 
BRANFORD, Conn., April 26, 2017 -- CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in non-invasive monitoring of cerebral oxygenation, announces that it will report financial results for the first quarter of 2017 on Wednesday, May 3, 2017, prior to the market’s opening. Management will host a conference call to discuss these results and answer questions at 10:00 a.m. Eastern time that day.
Conference call dial-in information is as follows:
- U.S. callers: (866) 239-5859
- International callers: (702) 495-1913
Individuals interested in listening to the live conference call via the Internet may do so by logging on to the Company's website: www.casmed.com.
A telephone replay will be available from 1:00 p.m. Eastern time on May 3, 2017, through 11:59 p.m. Eastern time on May 17, 2017. Replay dial-in information is as follows:
- U.S. callers: (855) 859-2056
- International callers: (404) 537-3406
- Conference ID number (U.S. and international): 6276331
- The replay will also be available at www.casmed.com.
About CASMED® – Monitoring What's Vital
CASMED products are designed to provide unique non-invasive monitoring solutions that are vital to patient care. The Company's FORE-SIGHT® Cerebral Oximeters provide a highly accurate, non-invasive measurement of tissue oxygenation in the brain. Direct monitoring of tissue oxygenation can provide a superior and powerful tool to alert clinicians to otherwise unrecognized and dangerously low levels of oxygen in the brain and empower them to improve patient care. In addition to FORE-SIGHT oximeters and accessories, the Company also provides proprietary non-invasive blood pressure monitoring solutions for OEM use. For further information regarding CASMED, visit the Company's website at www.casmed.com.
Company Contacts
CAS Medical Systems, Inc.
Jeffery A. Baird
Chief Financial Officer
(203) 315-6303
[email protected]
Investors
LHA
Bruce Voss / Jody Cain
(310) 691-7100
[email protected]
[email protected]
@LHA_IR_PR
